Showing results (2601-2610 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|July 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancerMehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.
The Oncologist|July 31, 2024
Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoringXinyu Gui, Xu Liang, Xiaoyi Guo, et al.
The Oncologist|July 2, 2024
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional studyJan Räder, Gabriele Ihorst, Mandy-Deborah Möller, et al.
The Oncologist|July 6, 2024
Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohortMarc-Antoine Benderra, Elena Paillaud, Amaury Broussier, et al.
The Oncologist|July 6, 2024
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutationsGautam U Mehta, Paz J Vellanki, Yi Ren, et al.
The Oncologist|July 2, 2024
Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancerWanwan Cheng, Ting Xu, Lu Yang, et al.
The Oncologist|June 22, 2024
Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitationsRitujith Jayakrishnan, David J Kwiatkowski, Michal G Rose, et al.
The Oncologist|July 22, 2024
A review of mitotane in the management of adrenocortical cancerJaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, et al.
The Oncologist|July 24, 2024
Clinical ethics consultation services: public-facing information on NCI-designated cancer center websitesErica Koranteng, Colin Cernik, Erin Gallagher, et al.
The Oncologist|June 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric massStefan Habringer, Jana Ihlow, Karsten Kleo, et al.
Pageof 571